Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease

被引:50
作者
Costacou, Tina [1 ]
Levy, Andrew P. [2 ]
机构
[1] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA
[2] Technion Israel Inst Technol, Technion Fac Med, Haifa, Israel
关键词
Haptoglobin genotype; Cardiovascular disease; Diabetes; VITAMIN-E SUPPLEMENTATION; CORONARY-ARTERY CALCIFICATION; HEMOGLOBIN SCAVENGER RECEPTOR; MIDDLE-AGED INDIVIDUALS; LOW-DENSITY-LIPOPROTEIN; ACUTE-PHASE PROTEINS; BETA-CAROTENE; IN-VITRO; RISK-FACTOR; VASCULAR COMPLICATIONS;
D O I
10.1007/s12265-012-9361-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the past decade, several longitudinal epidemiological studies have brought attention to the haptoglobin genotype and its importance in determining diabetic vascular disease risk. This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus.
引用
收藏
页码:423 / 435
页数:13
相关论文
共 112 条
[91]  
SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354
[92]   Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention [J].
Sarnak, MJ ;
Levey, AS ;
Schoolwerth, AC ;
Coresh, J ;
Culleton, B ;
Hamm, LL ;
McCullough, PA ;
Kasiske, BL ;
Kelepouris, E ;
Klag, MJ ;
Parfrey, P ;
Pfeffer, M ;
Raij, L ;
Spinosa, DJ ;
Wilson, PW .
HYPERTENSION, 2003, 42 (05) :1050-1065
[93]   Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes [J].
Simpson, Melissa ;
Snell-Bergeon, Janet K. ;
Kinney, Gregory L. ;
Lache, Orit ;
Miller-Lotan, Rachel ;
Anbinder, Yefim ;
Rewers, Marian J. ;
Levy, Andrew P. .
CARDIOVASCULAR DIABETOLOGY, 2011, 10
[95]   Assignment of the binding site for haptoglobin on apolipoprotein A-I [J].
Spagnuolo, MS ;
Cigliano, L ;
D'Andrea, LD ;
Pedone, C ;
Abrescia, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) :1193-1198
[96]   Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction [J].
Suleiman, M ;
Aronson, D ;
Asleh, R ;
Kapeliovich, MR ;
Roguin, A ;
Meisel, SR ;
Shochat, M ;
Sulieman, A ;
Reisner, SA ;
Markiewicz, W ;
Hammerman, H ;
Lotan, R ;
Levy, NS ;
Levy, AP .
DIABETES, 2005, 54 (09) :2802-2806
[97]  
Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X
[98]   Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes:: a 12-year observation study of 462 patients [J].
Torffvit, O ;
Lövestam-Adrian, M ;
Agardh, E ;
Agardh, CD .
DIABETIC MEDICINE, 2005, 22 (06) :723-729
[99]   Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine:: studies using deuterated α-tocopheryl acetates [J].
Traber, MG ;
Elsner, A ;
Brigelius-Flohé, R .
FEBS LETTERS, 1998, 437 (1-2) :145-148
[100]   Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland [J].
Tuomilehto, J ;
Borch-Johnsen, K ;
Molarius, A ;
Forsén, T ;
Rastenyte, D ;
Sarti, C ;
Reunanen, A .
DIABETOLOGIA, 1998, 41 (07) :784-790